Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday.
Interacting with students at the India International Science Festival in Bhopal, Ella also said that the homegrown vaccine for the lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month.
"Our nasal vaccine will be officially launched on January 26, on Republic Day," Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the Maulana Azad National Institute of Technology (MANIT).
In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Featured Video Of The Day
India To Induct 5.5-Gen Stealth Fighter Jet AMCA By 2035: DRDO Chairman
Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent Covid Vaccinated Pregnant Women At Lower Risk Of Caesarean Births: Study Fact Check: Can Covaxin Lead To Death After 2 Years Of Vaccination? 150 mg Semen In Kolkata Doctor's Body, Suspect Gang-Rape: Parents To Court Trump, Musk Groove To Bee Gees' 'Stayin' Alive' In AI-Video Now Viral "Want To Ask Congress...": Mamata Banerjee Snaps At Ally In Rape-Murder Case US Judge Says "Monopolist" Google Can't Avoid App Store Reforms NASA To Decide Stranded Starliner Astronauts' Route Home By End Of Month Mob Vandalises Hospital During Protest Over Kolkata Horror Track Latest News Live on NDTV.com and get news updates from India and around the world.